Legal Representation
Attorney
Timothy H. Hiebert
USPTO Deadlines 2 active 2 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
OPPOSITION
Notice of Publication |
NPUB | Feb 16, 2023 | 872 days overdue | Medium | Until Mar 16, 2023 |
|
ITU SOU
Notice of Allowance Mailed - SOU Required |
NOAM | Sep 14, 2023 | 662 days overdue | High | Until Mar 14, 2024 |
Application History
33 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 27, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Jun 27, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Jun 3, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jun 2, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Mar 10, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Mar 9, 2025 | IUAF | S | USE AMENDMENT FILED |
| Sep 9, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Sep 9, 2024 | EXT3 | S | SOU EXTENSION 3 FILED |
| Sep 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 9, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 14, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 13, 2024 | EXT2 | S | SOU EXTENSION 2 FILED |
| Mar 13, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Mar 13, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jul 18, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 14, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jul 14, 2023 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jul 14, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 14, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 17, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 17, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 28, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Dec 15, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 13, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Dec 12, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Dec 12, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jul 25, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 25, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jul 25, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jul 20, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 14, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Jan 13, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 11, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Pharmaceutical research and development in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, targeted genomic insertion, targeted genomic integration, genetic diseases, gene therapy and cell therapy; Medical laboratory services in the nature of gene editing for developing cells and protein RNA complexes for medical use
First Use Anywhere:
Mar 1, 2022
First Use in Commerce:
Mar 1, 2022
Additional Information
Design Mark
The mark consists of a stylized double helix design which incorporates a stylized letter "S".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
042